CNSP Stock Analysis: Buy, Sell, or Hold?
CNSP - CNS Pharmaceuticals, Inc. Common Stock
$5.83
-0.17 (-2.83%)
▼
5d:
+5.62%
30d:
+7.76%
90d:
+15.45%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When CNSP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: CNSP shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: CNSP shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: CNSP is currently trading at $5.83, which is considered extended relative to its 30-day fair value range of $5.00 to $5.71.
Technical Outlook: Technically, CNSP is in a uptrend. Immediate support is located at $4.85, while resistance sits at $6.19.
Market Sentiment: CNSP scores 23/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $10.00 (+71.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CNSP is in a uptrend. Immediate support is located at $4.85, while resistance sits at $6.19.
Market Sentiment: CNSP scores 23/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $10.00 (+71.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$5.00 -
$5.71
Company Quality Score
33/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
26.3%
All Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (23/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 71.5% below Wall St target ($10.00)
- WARNING: Composite score 33/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$5.00 -
$5.71
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$4.85
Resistance Level
$6.19
Current Trend
Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.51
Wall Street Target
$10.00
(+71.5%)
Share & Embed Analysis
Last updated: August 23, 2026 11:00 AM ET
Data refreshes hourly during market hours. Next update: 12:00 PM
Data refreshes hourly during market hours. Next update: 12:00 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CNSP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$91 | 42 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$285 | 66 BUY |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$35 | 50 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$108 | 52 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$127 | 41 HOLD |
